Novavax Inc vs Zeta Global Holdings Corp — how do they compare? Novavax Inc trades at $8.06 (market cap $1.30B), while Zeta Global Holdings Corp trades at $21.18 (market cap $5.32B). The key difference: Zeta Global Holdings Corp is far larger — about 4.1× Novavax Inc's market cap, and Zeta Global Holdings Corp is trading nearer its 52-week high, Novavax Inc nearer its low. Which is the better fit depends on your goals.
| NVAX | ZETA | |
|---|---|---|
Market Cap | $1.30B | $5.32B |
Sector | Health | Technology |
52-Week High | $11.19 | $25.24 |
52-Week Low | $6.22 | $14.55 |
Enterprise Value | $800.50M | $5.23B |
Trailing returns across standard periods
Latest headlines on both assets
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →Zeta Global is a leading data-driven marketing technology company that provides an omnichannel AI Marketing Cloud. By leveraging a proprietary data cloud of over 2.4 billion deterministic identities, it enables enterprise brands to acquire, grow, and retain customers through predictive intelligence and automated, agentic workflows.
Read more on ZETA →